Chunaram Choudhary

Chunaram Choudhary is a Professor at the Novo Nordisk Foundation Center for Protein Research within the Faculty of Health Sciences at the University of Copenhagen, where he has served as research director since 2013. His work bridges molecular biology and systems-level proteomics to decode cellular signaling networks.

Education & Career

• PhD from University of Münster (2006)
• Postdoctoral research at Max Planck Institute for Biochemistry, Martinsried
• Joined University of Copenhagen in 2009 through recruitment by Mathias Mann for the newly established protein research center

Research Focus

Choudhary pioneers systems-based analyses of protein post-translational modifications, particularly acetylation and ubiquitylation dynamics. His group developed groundbreaking mass spectrometry methods to map global protein interaction networks, revealing how chemical modifications like lysine acetylation regulate cellular processes. This work has direct implications for understanding cancer treatment resistance, as pharmaceutical efficacy depends on protein network states. His research integrates proteomics, cell biology, and computational modeling to decode signaling pathways in health and disease.

Scientific Recognition

• EliteForsk Award (2019) for groundbreaking discoveries in protein acetylation mechanisms
• ERC-Consolidator grant recipient
• EMBO Young Investigator
• Over 10,000 citations across publications in top-tier journals including Nature and Cell

Leadership & Impact

As research director, Choudhary leads an international team developing proteomics-based methodologies that have redefined understanding of cellular signaling. His work on protein networks has established the Danish Protein Research Center as a global leader in mass spectrometry applications. He advocates for international scientific collaboration, criticizing rising nationalism's detrimental impact on research progress. His lab's discoveries regarding acetylation signaling regulators provide new targets for stabilizing genomic integrity in disease contexts.